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Pathological calcium-containing crystals accumulating in the joints, synovial fluid, and soft
tissues are noted in most elderly patients, yet arthritic crystal formation remains idiopathic.
Interestingly, elevated lactic acid and bone erosion are frequently among the comorbidities
and clinical features of patients with highest incidence of crystal arthropathies. This work
shows that bone particulates (modeling bone erosion) dissolve in lactic acid and directly
generate crystals, possibly presenting a mechanism for crystal accumulation in
osteoarthritis.
Methods and results
Micronized human bone (average particle size of 160 μm x 79 μm) completely dissolved in
lactic acid in 48 hours, and in synovial fluid with 500 mMol lactic acid in 5 days, generating
birefringent rhomboid and rod-shaped crystals. SEM analysis with energy dispersive x-ray
spectroscopy of these crystals showed average dimensions of around 2 μm x 40 μm, which
contained oxygen, calcium and phosphorous at 8.64:1.85:1. Raman spectroscopy of the
generated crystals further showed 910/cm and 1049/cm peaks, aligning with calcium oxa-
late monohydrate and calcium pyrophosphate, respectively.
Conclusions
This work shows that lactic acid and micronized mineralized bone together directly generate
calcium-containing crystals. These observations may provide insights into the elusive etiol-
ogy of arthritis with crystal involvement, possibly indicating lactic acid as a clinical target for
treatment.
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Introduction
Osteoarthritis (OA) is the most prevalent human joint disorder and a leading cause of disabil-
ity[1]. However, with its complex and likely multifactorial pathogenesis, OA remains idio-
pathic. Poor understanding of OA etiology has meant poor therapeutic options[2], with
progressive destruction leading to total joint replacement. At least 70% of OA synovial fluid
samples have calcium-containing crystals[3], yet whether crystals are at the root of OA or are
downstream in relation to joint damage is under debate[4]. Pathological calcium and phos-
phate containing crystals in osteochondral regions of joints, in the surround joint soft tissue
and in synovial fluid are commonly noted in most forms of osteoarthritis[5,6]. Basic calcium
phosphate (BCP) and calcium pyrophosphate dehydrate (CPP) are the most commonly found
crystals in articular cartilage and synovial fluid[7], along with, very rarely, calcium oxalate
monohydrate (COM) [8]. However, multiple species of crystals are often found together in the
same patient sample[8].
Besides gout, calcium pyrophosphate deposition disease (CPPD) (or pseudogout) is the
most common idiopathic crystal arthropathy[5,6], with knee as the most commonly involved
joint, yet with polyarticular crystal deposition seen in two-thirds of patients. CPPD is esti-
mated to affect 15% of people aged 65–74, and 50% of people age 84 or older[5,9]. CPP crystals
present as rhomboid or rod-shaped structures and are weakly positive in birefringence under
compensated polarized light microscopy, while the crystals are non-birefringnent for BCP
deposition diseases[10]. There is no known effective method of removing calcium-containing
crystals deposited in the synovium, bound to cartilage (common in CPP) or soft tissues.
The non-apatitic carbonate and phosphate groups on bone minerals (calcium phosphate
[Ca3(PO4)2] or hydroxyapatite [Ca10(PO4)6(OH)2]) are reported to be very biologically active,
which may lead to dissolution of the hard tissue such as in normal remodelling[11]. CPP
(Ca2PO7) or BCP may thus be generated as crystals from the breakdown of bone in the pres-
ence of reactive lactic acid (C3O6H3) or lactate (CH3CH(OH)COO
-). Further, CPPD is report-
edly somewhat difficult to distinguish from erosive OA clinically[12], linking bone particulate
to arthritic crystals.
In humans, normal resting lactic acid levels range from 0.5–1.8 mmol/L. However, when
CPP crystals are detected, 4.2–11.2mmol/L of lactic acid has been reported, with elevated pH
[13], and up to 10–24 times normal levels in the synovial fluid for rheumatoid arthritis and
OA[13]. Lactic acid elevation is further a recurring clinical feature in crystal arthropathy
comorbidities (Table 1), along with bone erosion. It is thus hypothesized that lactic acid, or
lactate, and eroded bone (modeled here with human micronized bone particulate) directly
generate calcium and phosphate-containing crystals, suggesting joint lactic acidosis is directly
mechanistically linked to crystal arthropathies. Supporting this hypothesis, this work reports
an original model system of micronized mineralized bone suspended in synovial fluid in the
presence of acids to study bone-derived crystal formation.
Methods
Bone particulate production
Human bones from three donors with informed research consent (generous gift via the
National Disease Research Interchange [NDRI]) were debrided, with the marrow and trabecu-
lar bone removed. Washed bone was micronized in a TekMar grinder and sieved to<125μm
and 125–750μm. Portions of the bone from the two sieved size ranges were demineralized
using 0.1M hydrochloric acid (SigmaAldrich, St. Louis, MO) and rinsed with phosphate buffer
to neutralize (SigmaAldrich, St. Louis, MO).
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Synovial fluid collection and crystal formation
Arthrocentesis was performed postmortem on the knees joint of 4 recently deceased male donors
(70–80 years old) with research consent and assessed microscopically for crystals (n = 1 with crys-
tals, n = 3 without) by a pathologist. Synovial fluid was stained with alizarin red S (SigmaAldrich,
St. Louis, MO) to ensure absence of hydroxyapatite, as compared to control samples. Normal syno-
vial fluid was combined with 0, 10, 50, 100 or 500 mMol of lactic acid, and with 100mg/ml of
micronized mineralized bone. These samples were incubated at 37˚C with and without shaking at
1000 RPM shaking (Eppendorf Thermomixer R, Hamburg, Germany) then observed microscopi-
cally with normal and polarizing light daily for two weeks.
Acid treatments of bone and minerals
100mg/ml of mineralized and demineralized bone particulate <125μm and 125–750μm from
3 donors were stirred at 750RPM combined with either 1M or stock lactic acid, phosphoric
acid, oxalic, hydrochloric acid, acetic acid, sulfuric acid, formic acid, citric acid, or trifluoroa-
cetic acid (all from SigmaAldrich, St. Louis, MO) at either 4˚C, room temperature (~21˚C), or
37˚C. Samples were taken a 2hrs, 8hrs, 16hrs, and every 24hrs for 2 weeks for microscopic
evaluation. The solubility of BCP, HA, and CPP (Sigma-Aldrich, St. Louis, MO) was also tested
in each acid at 100mg/ml and imaged under normal and polarized light. Samples were exam-
ined for the appearance of crystals by an Olympus BX41 microscope with a polarizer. CPPD
crystals from arthrocentesis were imaged as positive controls.
Scanning electron microscopy (SEM)
SEM analysis was performed on a JEOL JSM-6060LV at Jefferson Labs (Newport News, VA).
Crystals generated from lactic acid dissolved mineralized bone were vacuum filtered
Table 1. Crystal arthropathy comorbidities linked with lactic acid and bone.
Crystal Arthropathy
Comorbidities
Major Clinical Manifestation Potential Lactic Acid & Eroded Bone Relationships
Gout Urate crystal formation Reduced uric acid excretion coincides with increased lactic acid concentration in
blood
Hemochromatosis Excess iron storage Elevated lactic acid consumption enhances iron uptake
Hypercalcemia Excess blood calcium level Possible eroded bone link




Elevated Serum Calcium (Above 10.2 mg/
dl)
Increased bone resorption
Hypomagnesemia Low Blood Magnesium Level (<0.7mmol/
L)
Associated with metabolic lactic acidosis
Hypophosphatasia Skeletal hypomineralization or
osteomalacia
Elevated endogenous inorganic pyrophosphate noted
Hypothyroidism Underactive thyroid gland Excess lactic acid is produced even at rest
Infection Sepsis from microbes Lactic acid accumulation
Ischemic Heart Disease Loss of blood flow and necrosis of
myocardium
Lack of oxygen shifts myocardium to anaerobic metabolism, elevating lactic acid
Osteoarthritis Degenerating cartilage and subchondral
bone
Eroded bone present micronized bone particles
Rheumatoid Arthritis Joint lining inflammation and bone
erosion
Lactic Acid builds up to repair inflamed muscles and joints, and erosion + fragments
of bone noted
Surgery Soft tissue ablation Lactic acid is the main component of Lactated Ringers & Hartmann’s solution
Trauma Tissue injury Lactic acid levels strongly associated with morbidity in level 1 trauma centers
https://doi.org/10.1371/journal.pone.0202373.t001
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(Whatman #4) and dried under a fume hood for 24 hours to partially dry the samples. Miner-
alized dry bone particulates were sputter coated with gold for SEM imaging. Uncoated Samples
for Energy-Dispersive X-Ray Spectroscopy (EDS) were imaged at low pressure (100Pa).
Quantitative SEM image analysis
ImageJ64 (NIH Shareware) was used to measure the average bone particle sizes and average
crystal dimensions. The averages are represented as the mean ± the standard deviation.
Raman spectroscopy
Mineralized bone particulate and lactic acid dissolved bone particulate were analyzed by Raman
spectroscopy on a Thermo Scientific smartRaman 532 nm with OMNIC software at Virginia
Commonwealth University (Richmond, VA). Crystals of calcium pyrophosphate, hydroxyl apatite,
calcium phosphate (Sigma-Aldrich) were used dry and at 100mg/ml in lactic acid to generate a
Raman reference library to compare the crystals generated from bone in lactic acid sample. Lactic
acid alone was analyzed to assess background interference. Micro-Raman at 633nm was performed
at ChemXLerate (Ann Arbor, MI) for bone in lactic acid samples.
Results
Crystal generation from bone in lactic acid
Of the nine acids tested, only lactic acid was found to dissolve and liquefy mineralized (but not
demineralized) bone particulate in the sub 125-micron diameter particle size range (hence-
forth referred to as “bone” per this proposed modeled system of eroded bone mineral interact-
ing with elevated local or systemic lactic acid). Eroded bone treated with lactic acid samples
presented as turbid, milky white appearance, similar to clinical samples with crystals. Lactic
acid treated bone formed rhomboid crystals in approximately 16 hours at 37˚C, forming rod-
shaped crystals in around 30 hours at room temperature, and forming rhomboid crystals
around 48 hours at 4˚C, from all 3 donors. Phosphoric and trifluoroacetic acids dissolved min-
eralized and demineralized bone but did not form crystals.
Under normal and polarized light microscopy, a donor knee synovial fluid sample with
pathologic crystals was found containing positively birefringent rod-shaped crystals (Fig 1A
and 1B) as a reference control. Adding 500mMol of lactic acid with 100mg/mL of bone to the
healthy synovial fluid (negative control, no crystals present initially) generated birefringent
rod-shaped crystals in the synovial fluid by 5 days of 37˚C incubation (Fig 1C and 1D), with
groups exposed to a lower concentration of lactic acid (100mM) and mineralized bone in nor-
mal synovial fluid formed rod-shaped crystals at 2 weeks. The dissolved rhomboid and rod-
shaped crystals from bone exhibited positive birefringence in both 500mMol lactic acid in
human synovial fluid (Fig 1D), and also formed crystals with micronized bone directly dis-
solved into 85% lactic acid (Fig 1E and 1F), comparable to control diseased synovial fluid with
crystals (Fig 1B). Birefringence was observed for most, but not all, crystals present. Titration of
deionized water to the crystal samples progressively resulted in shrinkage and dissolution of
the crystals. Lactic acid dissolved bone at 100mg/ml from two unique donors imaged by SEM
showed relatively homogeneous crystals with average length of 39.53μm by 2.07μm width, rela-
tive to the starting bone particulate averaging 160.36μm x 78.79μm (Fig 2A and 2C).
Crystal elemental analysis
SEM analysis with EDS of micronized mineralized bone alone (Fig 3A) is compared to crystals
generated from bone in synovial fluid with 500mMol lactic acid (Fig 3B), the latter of which
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showed atomic percentages of calcium and phosphate in the crystals at ratio of O:Ca:P at
8.64:1.85:1 (n = 5). Micro-Raman spectroscopy (633nm) of crystals from bone in lactic acid
did not detect the peak for hydroxyapatite at 960/cm yet the spectrum does contain the domi-
nant 1049/cm band used to diagnose CPPD clinically (Fig 4), suggesting the presence of Ca-O
and P-Ca bonds. This 1049/cm peak was also seen in CPP crystals controls, but not BCP in lac-
tic acid, as tested by Raman spectroscopy at 532nm.
Discussion
Better understanding of the causes of crystal formations are still needed to reduce, treat, or pre-
vent the formation and deposition of arthritic crystals. Lactic acid has been considered a
byproduct or correlated feature of arthritis involving crystals for decades[13]. This work pres-
ents a hypothetical pathogenesis for calcium-containing crystal, where micronized bone
(modeling eroded bone) and lactic acid are directly shown to generate crystals analogous to
those common in various forms of OA, being the first time that this has been experimentally
Fig 1. Crystals generated from lactic acid treated micronized bone. Human knee synovial fluid was collected from a donor that was
diagnosed with CPPD, containing crystals seen under normal (A) and polarized light (B) microscopy. Synovial fluid from a second male
donor without crystals present was mixed with 500mMol of lactic acid (LA) and 100mg/ml of micronized mineralized bone (mBone), which
produce birefringent crystals after 5 days of incubation at 37˚C (C, D). Using 85% lactic acid exposure to micronized mineralized bone,
rhomboid crystals are noted to form initially (around 18 hours) followed by rod shaped crystals by 48 hours in solution (E). These crystals in
lactic acid also exhibit birefringence under polarized light (F) and are further stable in this form for at least a month. Crystal morphologies of
lactic acid combine with calcium phosphate (G, H) and hydroxyapatite (I, J) are also represented, with distinctly different morphologies
present. All images captured using 40x objective.
https://doi.org/10.1371/journal.pone.0202373.g001
Fig 2. SEM imaging of bone particulates and lactic acid generated crystals from mineralized bone. Representative images of micronized mineralized human
bone (A), and the crystals generated from lactic acid exposure of micronized mineralized bone (still partially wet in acid) (B) are shown by SEM. The bone
particle and resulting crystal size distribution is further quantified (C).
https://doi.org/10.1371/journal.pone.0202373.g002
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reported. A proposed mechanism of arthritic calcium-containing crystal formation in joints is
illustrated in Fig 5.
Bone is solubilized in lactic acid to form crystals, as may be occurring in arthritic bone and
cartilage from erosions. For synovial fluid, 500mMol of lactic acid was required in around 5
days of exposure to generate rhomboid and rod-like crystals (Fig 1). Below, we propose a pos-
sible mechanism for the reaction of lactic acid and hydroxyapatite (Fig 6) to form crystals. In
the first step, lactic acid reacts with hydroxyapatite at the site of calcium forming intermediate
1. The dissociation of intermediate 1 forms a precursor of the final product with the formation
of intermediate 2. In the final state, the presence of oxygen in the surrounding interacts with
intermediate 2 to form calcium phosphate and calcium oxalate monohydrate.
Fig 3. Energy-dispersive X-ray spectroscopy analysis of crystals generated from micronized bone in lactic acid. Representative EDS
spectra and quantitative results of the untreated micronized mineralized bone particulate (A) and lactic acid treated crystals (B) are
shown. Micronized mineralized human bone (100mg/ml) dissolved in synovial fluid with 500mMol of lactic acid was analyzed by EDS
after vacuum drying, which, while still slightly wet with lactic acid, presented an atomic percentage for calcium, phosphate, and oxygen
between that of BCP and CPP. EDS was performed on two individually processed donors for each condition (n = 2), yielding elemental
composition results that were not significantly different.
https://doi.org/10.1371/journal.pone.0202373.g003
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Fig 4. Raman spectroscopy analysis of crystals generated from micronized bone in lactic acid. Micro-Raman spectroscopy analysis was
performed on lactic acid (LA) with micronized mineralized bone-generated crystals from two unique samples from two different donors
(labeled as “LA + mBone Crystals 1 & 2”) and compared to lactic acid alone, with imaging targeted at a single crystal for analysis. The full
spectra are represented in A, with zoomed regions from around 0–1900 Raman shift/cm-1 in B, and around 2000–3700 Raman shift/cm-1
Direct crystal formation from micronized bone and lactic acid
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In this study, while the lactic acid concentrations used are higher than physiologic, the reac-
tion kinetics of the acid with bone would occur at lower concentrations as well, albeit with req-
uisite additional reaction time. The higher concentrations of lactic acid tested where thusly
chosen to speed the chemical reaction to facilitate analyses. Lactic acid dissolved bone crystals
magnified in panel C. A dominant peak seen at 1049/cm (using 633nm spectroscopy) is shown in the experimental traces (A,B), which is a
peak commonly reported for calcium pyrophosphate crystals clinically. Further, the hydroxyapatite peak (commonly reported at 960/cm)
is absent, yet a slight peak is noted around 900/cm, indicative of calcium oxalate monohydrate.
https://doi.org/10.1371/journal.pone.0202373.g004
Fig 5. Proposed mechanism of arthritic calcium-containing crystal formation in joints. (A) Illustration showing the theoretical
pathological origin of calcium-containing crystals as generated in the synovial space of the knee from the interaction of eroded bone (B)
and lactic acid (C) resulting in progressive degradation of the injured bone to generate calcium-containing crystals.
https://doi.org/10.1371/journal.pone.0202373.g005
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dissolved under increased hydration, similar to clinical reports[13] suggesting hydration as a
possible therapeutic consideration and perhaps related to the 33% decrease in body water con-
tent in the elderly compared to the young[14]. While the size of the crystals generated in this
study are larger than those seen clinically for CPP or BCP, the high saturation of bone and
higher acid concentration tested may allow for crystallization to occur beyond what is com-
mon clinically.
SEM-EDS results of micronized bone in 85% lactic acid and of micronized bone in
500mMol of lactic acid in synovial fluid show the presence of oxygen:calcium;phosphate in the
crystals at a ratio of 8.64:1.85:1 (Fig 3). This ratio is not perfectly fitting with CPP (Ca:P at 1:1)
or BCP (Ca:P at 2:1), yet as the samples are of dissolved bone crystals in wet solution, free bone
salts in the solution may be interfering with the measurements. Raman spectroscopy was thus
used to further identify the crystals, where the spectra indicated a dominant peak at 1049/cm,
positively identifying CPP, whereas the hydroxyapatite peak at 960/cm is absent, with a slight
peak at around 910/cm suggesting calcium oxalate crystals (Fig 3). The reference library gener-
ated from all Raman samples at 532nm suggested that lactic acid dissolved bone samples were
most similar to CPP controls.
Review of the literature (Table 1) revealed elevated lactic acid levels, bone resorption and
erosion frequently co-associated with crystal arthropathy comorbidities, further linking lactic
acid and crystal formation. Subsequent epidemiological studies assessing lactic acid involve-
ment in arthritis are clearly warranted. While treating cartilage and bone erosion in arthritis
has proven incredibly challenging, approaches addressing lactic acid reduction may hold
promise. Care strategies to reduce lactic acid levels to potentially inhibit or reverse crystal for-
mation may include improved hydration, reduced lactic acid-containing food consumptions,
increased physical activity, dietary supplementation (e.g. beta alanine, taurine) and possible
pharmacological interventions. Interestingly, lactic acid in the presence of calcium also forms
calcium lactate as crystals during neutral fermentation[15].
Fig 6. Proposed mechanism of crystal formation. Synthesis of calcium pyrophosphate and calcium oxalate monohydrate from lactic acid and
hydroxyapatite.
https://doi.org/10.1371/journal.pone.0202373.g006
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For additional future directions, it may prove informative to test synovial membrane cells
from normal and OA individuals to assess if either tends to produce more lactic acid. Interest-
ingly, synovial fluid further contains the lactic acid dehydrogenase (LDH) enzyme, suggesting
importance of joint-lactic acid balance[16]. LDH therapy (e.g. gene therapy) may further be
tested in animal models for controlling crystal-containing OA. Further, lactic acid may be
administered to animals to potentially induce bone erosion, OA and crystal formation, possi-
bly even spurring rheumatoid arthritis symptoms.
Conclusion
We report on a proposed model for the etiology of osteoarthritis with crystal involvement,
where eroded bone particulate in the presence of lactic acid are shown to directly generate cal-
cium-containing crystals. These observations are significant because of the current idiopathic
nature of calcium-containing crystal arthropathies. This work shows that lactic acid, a com-
mon acid in the body that accumulates with age and with disease, is remarkably found to
experimentally dissolve bone particulate and he dissolved bone salts form stable crystals that
resemble those found in some forms of osteoarthritis. These results and the hypothesis herein
present a plausible direct cause of osteoarthritis with crystal involvement from local eroded
bone and the elevated lactic acid in the synovial fluid and systemically, as is commonly
reported with osteoarthritis.
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